Autopsy report · NCT03246399
A Study of the Safety, Tolerability, and Pharmacokinetics of SM04690 Injectable Suspension Following Single Intradiscal Injection in Subjects With Degenerative Disc Disease
Cause of deathFunding or business
“Study stopped due to business reasons, following full enrollment of the first dose cohort.”
Life of this trial
- Ran for about 1 year 4 months before it stopped.
- 6 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 1
- Sponsor
- Biosplice Therapeutics, Inc.
- Sponsor type
- Industry
- Conditions
- Degenerative Disc Disease
- Interventions
- SM04690
- Participants
- 6
- Sites
- 4
- Countries
- United States
Trials that died the same way
- The Role of Osteopathic Manipulative Medicine in Recovery From Concussions
“Due to lower than anticipated enrollment number, this study was stopped.” - Tai Chi and Wellness Education for Older Veterans
“The study was stopped after completing 2 cohorts instead of the intended 3 cohorts. This was due to logistical issues and budget-related issues (timing of being able to spend the funds).” - Hand Injected Ventriculography vs. Power Injected Left Ventriculography
“Study was stopped due to low enrollment.” - Avelumab (Bavencio) With IL-15 in Subjects With Clear-Cell Renal Carcinoma
“This study was terminated early due to manufacturer withdrawal of support (study medication) due to lack of enrollment.” - Nasal High-frequency Jet Ventilation (nHFJV) Following Extubation in Preterm Infants
“Study stopped due to safety reasons.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.